Skip to main content
TipRanks
Go Ultimate75% OFF

LianBio Sponsored ADR (LIANY) Financial Statements

65 Followers

LianBio Sponsored ADR Financial Overview

LianBio Sponsored ADR's market cap is currently $5.69M. The company's EPS TTM is $2.92; its P/E ratio is 1.08; and it has a dividend yield of 955.56%. LianBio Sponsored ADR has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -801.40K$ -1.33M$ -1.00M$ -526.00K
Operating Income$ -1.27M$ -38.86M$ -99.54M$ -125.20M$ -195.57M
EBITDA$ -1.27M$ 3.26M$ 312.91M$ -109.49M$ -195.52M
Net Income$ 4.91M$ 2.48M$ 311.14M$ -110.16M$ -196.56M
Balance Sheet
Cash & Short-Term Investments$ 9.39M$ 51.70M$ 567.37M$ 302.36M$ 383.24M
Total Assets$ 20.52M$ 63.72M$ 617.96M$ 319.96M$ 426.33M
Total Debt$ 0.00$ 0.00$ 2.46M$ 4.34M$ 4.83M
Net Debt$ -9.39M$ -51.70M$ -436.13M$ -74.88M$ -223.34M
Total Liabilities$ 14.00K$ 859.00K$ 36.77M$ 26.31M$ 39.01M
Stockholders' Equity$ 20.51M$ 62.87M$ 581.20M$ 259.87M$ 353.55M
Cash Flow
Free Cash Flow$ 4.95M$ 3.75M$ 258.56M$ -100.91M$ -165.12M
Operating Cash Flow$ 4.95M$ 3.75M$ 258.94M$ -99.07M$ -164.17M
Investing Cash Flow$ 0.00$ 128.85M$ 99.31M$ -69.12M$ -156.14M
Financing Cash Flow$ -47.38M$ -550.70M$ 1.78M$ 1.71M$ 313.69M

Currency in USD

LianBio Sponsored ADR Earnings and Revenue History

-250M0250M500M0 %0.4 %0.8 %1.2 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin

LianBio Sponsored ADR Liabilities to Assets

0250M500M750M0 %4 %8 %12 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

LianBio Sponsored ADR Cash Flow

-600M-400M-200M0200M400M2019202020212022202320242025OperatingInvestingFinancing

LianBio Sponsored ADR Forecast EPS vs Actual EPS

-1012345Q4 22Q1 23Q2 23Q3 23Q4 23Q1 24EPS EstimateBeatMiss